ask="2.1500"
ask_size="25000"
average_daily_volume="6075"
bid="2.0100"
bid_size="25000"
book_value="0.3830"
change="-0.0388"
change_from_200_day_moving_average="0.2089"
change_from_50_day_moving_average="0.0411"
change_from_52_week_high="-0.1886"
change_From_52_week_low="0.9714"
change_in_percent="-1.8563%"
close="2.0514"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2090"
ebitda="-2.96M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="10636000"
high="2.1500"
high_52_weeks="2.2400"
last_trade_date="1/11/2017"
last_trade_price="2.0514"
last_trade_size="100"
last_trade_time="3:58pm"
low="2.0200"
low_52_weeks="1.0800"
market_capitalization="35.04M"
moving_average_200_day="1.8425"
moving_average_50_day="2.0103"
name="ProPhase Labs
Inc."
notes="N/A"
one_year_target_price="15.5500"
open="2.1500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+11.3366%"
percent_change_from_50_day_moving_average="+2.0445%"
percent_change_from_52_week_high="-8.4196%"
percent_change_from_52_week_low="+89.9444%"
previous_close="2.0902"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.4574"
price_per_sales="1.6553"
revenue="21.57M"
shares_outstanding="17080000"
short_ratio="0.9200"
stock_exchange="NCM"
symbol="PRPH"
volume="21821"
weeks_range_52="1.0800 - 2.2400"
